Ox bile extract

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Ox bile extract
DrugBank Accession Number
DB14016
Background

Not Available

Type
Biotech
Groups
Approved, Experimental, Investigational
Synonyms
  • Beef bile
  • Bos bovis bile
  • Bos taurus bile
  • Bovine bile
  • Fel tauri
  • Ox bile
  • Purified oxgall
  • Sodium choleate

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatCholecystopathyCombination Product in combination with: Activated charcoal (DB09278), Pancrelipase (DB00085)••••••••••••••••••• ••••••• ••••••
Treatment ofChronic constipation••• •••
Used in combination for symptomatic treatment ofDyspepsiaCombination Product in combination with: Activated charcoal (DB09278), Pancrelipase (DB00085)••••••••••••••••••• ••••••• ••••••
Treatment ofGallstones••• •••
Treatment ofHerpes zoster••• •••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Aluminium phosphateThe serum concentration of Ox bile extract can be decreased when it is combined with Aluminium phosphate.
Aluminum chlorideThe serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chloride.
Aluminum chlorohydrateThe serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chlorohydrate.
Aluminum hydroxideThe serum concentration of Ox bile extract can be decreased when it is combined with Aluminum hydroxide.
Aluminum oxideThe serum concentration of Ox bile extract can be decreased when it is combined with Aluminum oxide.
Food Interactions
  • Take after a meal.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Alka-pan TabletsOx bile extract (35 mg) + Betaine hydrochloride (20 mg) + Bromelains (50 mg) + Pancrelipase (135 mg) + Papaya (125 mg)TabletOralMorter HealthsystemNot applicableNot applicableCanada flag
DygestOx bile extract (75 mg) + Betaine hydrochloride (90 mg) + Pancrelipase (200 mg) + Papain (100 mg) + Peppermint (50 mg) + Pepsin (125 mg)TabletOralCreative Nutrition Canada Corp.1987-12-312007-07-11Canada flag
Enzyme TabletsOx bile extract (8.125 mg) + Betaine hydrochloride (65 mg) + Pancrelipase (100 mg) + Pancrelipase amylase (130 mg) + Papain (65 mg) + Pepsin (65 mg)TabletOralGeneral Nutrition Canada Inc.2001-10-202007-08-01Canada flag
FLATON ENTERIK DRAJE, 30 ADETOx bile extract (25 mg) + Hemicellulase (50 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg)Tablet, coatedOralBİLİM İLAÇ SAN. VE TİC. A.Ş.1989-03-14Not applicableTurkey flag
FLATON ENTERIK DRAJE, 60 ADETOx bile extract (25 mg) + Hemicellulase (50 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg)Tablet, coatedOralBİLİM İLAÇ SAN. VE TİC. A.Ş.1989-03-14Not applicableTurkey flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
StozymeOx bile extract (5.21 1/1001) + Dimethicone (5.21 1/1001) + Hemicellulase (10.42 1/1001) + Pancrelipase (36.46 1/1001)TabletOralChunwoo Pharmaceutical Co., Ltd.2019-10-19Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
ET3651ZLOU
CAS number
Not Available

References

General References
Not Available
RxNav
1310249

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
2CompletedTreatmentObesity / Overweight / Type 2 Diabetes Mellitus1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
LiquidOral
Tablet, coatedOral
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available

Drug created at April 25, 2018 22:43 / Updated at September 28, 2021 21:54